BNC KOREA, Inc. researches and develops healthcare products that will lead the next generation bio markets for medical devices, pharmaceuticals, and cosmeceutical products containing physiologically active substances by processing biomaterials. We are the first Korean bio-venture to develop hyaluronic acid dermal filer as a patented technology, we are focused on Biomaterials business with steady R&D and GMP facilities. Also, we have an active ODM/OEM business by providing the best quality in the bio-material sector. We have been widening forward to APIs businesses, and pharmaceutical businesses following development of Botulinum toxin.
Company Details
- Employees
- 8
- Founded
- -
- Address
- 42 Nonhyeon-Ro 38-Gil, Damyung Building 5th Floor,korea, Republic Of
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.bnckorea.co.kr
- HQ
- Seoul, Gangnam-gu
Bnc Korea, Inc. Questions
Bnc Korea, Inc.'s website is http://www.bnckorea.co.kr
Bnc Korea, Inc.'s LinkedIn profile is https://kr.linkedin.com/company/bnc-korea-inc
Bnc Korea, Inc. has
8 employees.
View email and phone details for 8
employees at Bnc Korea, Inc..
Bnc Korea, Inc.'s industry is
Pharmaceutical Manufacturing
Bnc Korea, Inc.'s top competitors are
Oligio.us,
Daewoong Pharmaceutical,
Vaim,
Oreon Life Science Co. Ltd.,
Jdbio Co., Ltd,
Bnc Global,
Regenbio Global, Inc.,
First Class Aesthetics Korea,
Bnc Global,
Jetema Co., Ltd.
Bnc Korea, Inc.'s categories are Pharmaceutical Manufacturing
Bnc Korea, Inc.'s founding year is 2007
